
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : Oncode Bridge Fund
Deal Size : Undisclosed
Deal Type : Funding
Oncode Institute and ArgoBio Launch Laigo Bio
Details : The company has additionally secured funding from Oncode Bridge Fund and ArgoBio to further develop its proprietary pipeline of targeted immunotherapies SureTACsR.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
February 08, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : Oncode Bridge Fund
Deal Size : Undisclosed
Deal Type : Funding
